Treatment of Neuropathic Pain

ABSTRACT

Neuropathic pain is a common symptom associated with peripheral neuropathy and can be as or more disabling than the effects of nerve damage from the neuropathy. Though treatment of the underlying pathophysiology causing neuropathies may not be possible, treatment of neuropathic pain is. The author reviews the major medications used, dosing schedules, and data from randomized controlled trials.

KEYWORDS

Neuropathic pain - tricyclic antidepressants - selective serotonin reuptake inhibitors

REFERENCES

• 1 Freynhagen R, Bennett M I. Diagnosis and management of neuropathic pain.  BMJ. 2009;  339 b3002
• 2 Attal N, Cruccu G, Baron R et al.. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision.  Eur J Neurol. 2010;  (Apr) 9
• 3 Jensen T S, Madsen C S, Finnerup N B. Pharmacology and treatment of neuropathic pains.  Curr Opin Neurol. 2009;  22(5) 467-474
• 4 Moulin D E, Clark A J, Gilron I Canadian Pain Society et al. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.  Pain Res Manag. 2007;  12(1) 13-21
• 5 Dworkin R H, O'Connor A B, Backonja M et al.. Pharmacologic management of neuropathic pain: evidence-based recommendations.  Pain. 2007;  132(3) 237-251
• 6 O'Connor A B, Dworkin R H. Treatment of neuropathic pain: an overview of recent guidelines.  Am J Med. 2009;  122(10, Suppl) S22-S32
• 7 Saarto T, Wiffen P J. Antidepressants for neuropathic pain.  Cochrane Database Syst Rev. 2007;  (4) CD005454
• 8 Eli Lilly and Co .Cymbalta prescribing information. Available at: http://www.cymbalta.com/index.jsp Accessed June 30, 2010
• 9 Lunn M P, Hughes R A, Wiffen P J. Duloxetine for treating painful neuropathy or chronic pain.  Cochrane Database Syst Rev. 2009;  (4) CD007115
• 10 Pfizer .Effexor prescribing information. Available at: http://www.effexor.com/ Accessed June 30, 2010
• 11 Pfizer .Neurontin prescribing information. Available at: http://www.pfizer.com/products/rx/rx_product_neurontin.jsp Accessed June 30, 2010
• 12 Wiffen P J, McQuay H J, Edwards J E, Moore R A. Gabapentin for acute and chronic pain.  Cochrane Database Syst Rev. 2005;  (3) CD005452
• 13 Gilron I, Bailey J M, Tu D, Holden R R, Jackson A C, Houlden R L. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial.  Lancet. 2009;  374(9697) 1252-1261
• 14 Endo Pharmaceuticals .Lidoderm prescribing information. Available at: http://www.lidoderm.com/hcp/default.aspx Accessed June 30, 2010
• 15 Eisenberg E, McNicol E, Carr D B. Opioids for neuropathic pain.  Cochrane Database Syst Rev. 2006;  3 CD006146
• 16 Hollingshead J, Dühmke R M, Cornblath D R. Tramadol for neuropathic pain.  Cochrane Database Syst Rev. 2006;  3 CD003726
• 17 Neuroges X. Qutenza prescribing information. Available at: http://www.qutenza.com/hcp/ Accessed June 30, 2010
• 18 Otto M, Bach F W, Jensen T S, Brøsen K, Sindrup S H. Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.  Pain. 2008;  139(2) 275-283
• 19 Semenchuk M R, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.  Neurology. 2001;  57(9) 1583-1588
• 20 GSK .Lamictal prescribing information. 2010. Available at: https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=ProductDetailPage&product_id=1244170588800&featureKey=600578 Accessed June 30, 2010
• 21 Wiffen P J, Rees J. Lamotrigine for acute and chronic pain.  Cochrane Database Syst Rev. 2007;  (2) CD006044
• 22 Vinik A I, Tuchman M, Safirstein B et al.. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies.  Pain. 2007;  128(1-2) 169-179
• 23 Jose V M, Bhansali A, Hota D, Pandhi P. Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy.  Diabet Med. 2007;  24(4) 377-383
• 24 Silver M, Blum D, Grainger J, Hammer A E, Quessy S. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.  J Pain Symptom Manage. 2007;  34(4) 446-454
• 25 UCB .Vimpat prescribing information. Available at: http://www.vimpat.com/ Accessed June 30, 2010
• 26 Shaibani A, Fares S, Selam J L et al.. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial.  J Pain. 2009;  10(8) 818-828
• 27 Wiffen P J, McQuay H J, Moore R A. Carbamazepine for acute and chronic pain.  Cochrane Database Syst Rev. 2005;  (3) CD005451
• 28 Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.  Acta Neurol Scand. 2006;  114(3) 177-180
• 29 Dworkin R H, O'Connor A B, Audette J et al.. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.  Mayo Clin Proc. 2010;  85(3, Suppl) S3-S14
• 30 Yuan R Y, Sheu J J, Yu J M et al.. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.  Neurology. 2009;  72(17) 1473-1478
• 31 Challapalli V, Tremont-Lukats I W, McNicol E D, Lau J, Carr D B. Systemic administration of local anesthetic agents to relieve neuropathic pain.  Cochrane Database Syst Rev. 2005;  (4) CD003345
• 32 Rogers M, Rasheed A, Moradimehr A, Baumrucker S J. Memantine (Namenda) for neuropathic pain.  Am J Hosp Palliat Care. 2009;  26(1) 57-59
• 33 Thisted R A, Klaff L, Schwartz S L et al.. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.  Clin Ther. 2006;  28(10) 1607-1618